Navigation Links
A research tale with a heart to match: Professor looks at cardiovascular disease in dogs
Date:8/3/2011

MANHATTAN -- For more than 15 years, Kansas State University researcher Michele Borgarelli has studied heart diseases in man's best friend.

But there is an interesting twist in his work with mitral valve disease: chronic mitral valve disease in dogs is similar to the same disease affecting humans, making Borgarelli's research beneficial to dog's best friend, too.

Further proof of the bond between owner and dog? Perhaps.

But for Borgarelli, Kansas State University associate professor of cardiology, the heart-filled similarities motivate him to learn more about mitral valve disease, the most common acquired cardiovascular disease in dogs.

The disease is a heart condition where the mitral valve -- one of the four valves in the heart -- deteriorates. As the valve deteriorates, more blood backflows through the valve and can lead to congestive heart failure.

"We know that the disease affects geriatric dogs very commonly," Borgarelli said. "I'm interested to know why some dogs progress faster and die from the disease when other dogs do not."

Small breed dogs, such as Cavalier King Charles spaniels, cocker spaniels, dachshunds, miniature poodles and Yorkshire terriers are more prone to chronic mitral valve disease. But Borgarelli's research has shown that the disease can also affect large breed dogs, such as German shepherds. He wants to search a list of factors to identify dogs more likely to progress to a severe disease stage.

"Although a lot of these patients never progress to heart failure, you don't want to wait until they get to an age where it is too late," Borgarelli said. "You want to identify these patients as early as possible."

About 70 percent of the dogs that are affected by mitral valve disease are not affected from heart failure and do not die from the disease.

"That's very similar to people," Borgarelli said. "There are some people who don't progress to heart failure even without any treatment. Treatments options are also different between people and dogs. Severely afflicted humans can have their deteriorated valve repaired or replaced. You cannot do that with dogs, yet. But surgery is going to be an option in the future for dogs, and because not every dog will be affected by heart failure, it is important to be able to identify dogs at higher risk for progression of the disease."

During a period of five years, Borgarelli and his research team conducted two population studies that involve more than 300 dogs. One population study, which was published in 2008, involved dogs that had mitral valve disease at different stages, from mild to severe. Another study, which the researchers are preparing for publication, involves dogs with the mild form of the disease.

The researchers found that 70 percent of pre-clinical dogs that have symptoms of the disease are still alive after six years. The dogs that experience heart failure have a median survival time of nine months after severe heart failure to 33 months after moderate heart failure.

Using echocardiographic examination, which creates an ultrasound-like image of the heart, the researchers have already found some indicators for severe forms of the disease. One such indicator is an enlarged left atrium in the heart, while other indicators include biomarkers, which involve evaluating blood samples.

Borgarelli is leading an Italian study of another indicator, called Brain Natriuretic Peptide, or BNP. The study, which started last year and will last until 2015, has two major goals: to evaluate if treatment with a combination of two drugs can delay the onset of clinical signs of mitral valve disease and to evaluate if any biomarker, including the peptide, can be used to identify patient risk.

For a third study, Borgarelli is applying a new noninvasive technique called contrast echocardiography to evaluate noninvasive myocardial perfusion -- an imaging procedure that can evaluate many heart conditions.

The study, sponsored by pharmaceutical company Boehringer Ingelheim, has just begun at Kansas State University's College of Veterinary Medicine Teaching Hospital and will continue until 2012. Researchers plan additional studies using new 3D technology to further evaluate the mitral valve. Their work is evidence of the rapid progress made on the disease in recent years, Borgarelli said.

"This disease was first described in the 1960s. What we knew about the disease in the 1960s was about the same as what we knew up until a few years ago," Borgarelli said. "Many questions have been resolved in just a few years."

But unanswered questions still exist, Borgarelli said, such as whether the disease is genetic and why some dogs progress to a more severe disease while others do not.

"Because it's such a common disease and because dogs are naturally models for studying the disease in humans -- those are reasons why I want to continue studying this disease," Borgarelli said.


'/>"/>

Contact: Michele Borgarelli
mborgare@k-state.edu
785-532-4237
Kansas State University
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to feel uncomfortable about ... than regular municipal or well water. The recent experience with lead contaminated water in ... a long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point Consulting, ... in KLAS: Software & Services for HIT Implementation Support & Staffing report with ... ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 hospitals ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Dr. Justin Scott ... their 2nd Annual No Cost Dental Day to individuals in need. The event is ... of this No Cost Dental Day is to provide dental care to community members ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  As people age, it ... multitude of recommended screenings and tests that are linked ... priority. However, for the majority of aging individuals, hearing ... planning. For the 37.5 million American adults who report ... present to make hearing health a 2016 healthy aging ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> Research ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology: